Press Releases Opthea Limited

Equities

Market Closed - Australian S.E. Other stock markets 07:10:59 14/05/2024 BST			5-day change	1st Jan Change
0.65 ^AUD	-3.70%		0.00%	+14.04%

04-03	Opthea Limited Announces Board Changes	CI
02-29	Opthea Posts H1 FY24 Loss per Share of $0.1623; R&D Expenses Jump	MT

Opthea Announces Upcoming Presentations at the Retina World Congress 2024	05-01	AQ
Opthea : Quarterly Activity Report - Form 6-K	04-30	PU
Opthea to Present at the OIS Retina Innovation Summit at ARVO	04-25	AQ
Opthea : to Present at the OIS Retina Innovation Summit at ARVO - Form 6-K	04-25	PU
Opthea Appoints John Han, PharmD, as VP Medical Affairs	04-08	AQ
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference	04-04	AQ
Opthea Appoints Sujal Shah to the Board of Directors	04-03	AQ
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024	03-19	AQ
Opthea to Participate in the Leerink Partners Global Biopharma Conference	03-05	AQ
Opthea Reports Half-Year Financial Results and Business Updates	02-28	AQ
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor	02-19	AQ
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept	02-14	AQ
Opthea Strengthens Team with Key Clinical and Regulatory Hires	02-01	AQ
Opthea to Receive US$35M Commitment and Additional US$50M Funding	12-27	GL
Opthea to Receive US$35M Commitment and Additional US$50M Funding	12-27	AQ
Opthea Receives A$8.8 million R&D Tax Incentive	12-19	GL
AusBiotech energised by new Board appointments	12-11	AQ
Opthea to Present at the FLORetina 2023 Congress	12-01	GL
Opthea to Present at the FLORetina 2023 Congress	12-01	AQ
Opthea : to Present at the FLORetina 2023 Congress - Form 6-K	11-30	PU

No results for this search